Request a document copy: Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis

all files (of this document) in restricted access
the file(s) you requested
Cancel